Maxcyte (MXCT) Gross Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 63.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -324.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 311.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 56.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -164.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 124.00
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn -6,888.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6,888.00
Dec 31, 2025 23,271.00
Sep 30, 2025 -5,303.00
Jun 30, 2025 3,165.00
Mar 31, 2025 6,402.00
Dec 31, 2024 48,497.00
Sep 30, 2024 -8,756.00
Jun 30, 2024 9,115.00
Mar 31, 2024 4,112.00
Dec 31, 2023 64,154.00
Sep 30, 2023 4,441.00
Jun 30, 2023 -11,657.00